BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23428866)

  • 1. Recent advancements in comprehensive genetic analyses for human hepatocellular carcinoma.
    Nishida N; Kudo M
    Oncology; 2013; 84 Suppl 1():93-7. PubMed ID: 23428866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early molecular and genetic determinants of primary liver malignancy.
    Feitelson MA; Pan J; Lian Z
    Surg Clin North Am; 2004 Apr; 84(2):339-54. PubMed ID: 15062649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
    Xue KX
    Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive genome sequencing of the liver cancer genome.
    Nakagawa H; Shibata T
    Cancer Lett; 2013 Nov; 340(2):234-40. PubMed ID: 23142287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next generation sequencing reveals genetic landscape of hepatocellular carcinomas.
    Li S; Mao M
    Cancer Lett; 2013 Nov; 340(2):247-53. PubMed ID: 23063663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma: epidemiologic and molecular biological aspects.
    Kao JH; Chen PJ; Chen DS
    Adv Cancer Res; 2010; 108():21-72. PubMed ID: 21034965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exome capture sequencing reveals new insights into hepatitis B virus-induced hepatocellular carcinoma at the early stage of tumorigenesis.
    Chen Y; Wang L; Xu H; Liu X; Zhao Y
    Oncol Rep; 2013 Oct; 30(4):1906-12. PubMed ID: 23912677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development.
    Hu L; Zhai X; Liu J; Chu M; Pan S; Jiang J; Zhang Y; Wang H; Chen J; Shen H; Hu Z
    Hepatology; 2012 May; 55(5):1426-31. PubMed ID: 22105689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic aspects of hepatocellular carcinogenesis.
    Ozturk M
    Semin Liver Dis; 1999; 19(3):235-42. PubMed ID: 10518303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel mouse models of hepatocarcinogenesis with stepwise accumulation of genetic alterations.
    Kim SK; Marusawa H; Eso Y; Chiba T; Kudo M
    Dig Dis; 2013; 31(5-6):454-8. PubMed ID: 24281020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational complex genotype of the hepatitis B virus X /precore regions as a novel predictive marker for hepatocellular carcinoma.
    Jang JW; Chun JY; Park YM; Shin SK; Yoo W; Kim SO; Hong SP
    Cancer Sci; 2012 Feb; 103(2):296-304. PubMed ID: 22136288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large-scale analysis of the genetic and epigenetic alterations in hepatocellular carcinoma from Southeast China.
    Su H; Zhao J; Xiong Y; Xu T; Zhou F; Yuan Y; Zhang Y; Zhuang SM
    Mutat Res; 2008 May; 641(1-2):27-35. PubMed ID: 18358501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.
    Kim MY; Park E; Park JH; Park DH; Moon WS; Cho BH; Shin HS; Kim DG
    Oncogene; 2001 Jul; 20(33):4568-75. PubMed ID: 11494152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries.
    Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K
    Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single nucleotide polymorphisms and risk of hepatocellular carcinoma in cirrhosis.
    Nahon P; Zucman-Rossi J
    J Hepatol; 2012 Sep; 57(3):663-74. PubMed ID: 22609306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation profiling of tumor suppressor genes and oncogenes in hepatitis virus-related hepatocellular carcinoma in northern India.
    Kiran M; Chawla YK; Kaur J
    Cancer Genet Cytogenet; 2009 Dec; 195(2):112-9. PubMed ID: 19963110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation of genetic polymorphisms of beta-catenin to hepatitis B virus-related hepatocellular carcinoma].
    Lai J; Gao ZL; Yang L; Chen W; Zhou X; Ke WM
    Ai Zheng; 2009 Jun; 28(6):607-11. PubMed ID: 19635198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between mutation on precore region of integrated HBV DNA and p53 gene mutation in hepatocellular carcinoma].
    Wang XH; Wang PL
    Ai Zheng; 2003 Jul; 22(7):715-8. PubMed ID: 12866962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.